Middle East & Africa Blood Collection Devices Market is expected to reach US$ 384.85 million by 2028

Publisher: The Insight Partners

Manual Blood Collection Segment to Hold Largest Share of Middle East & Africa Blood Collection Devices Market During 2022–2028

According to our latest study on “Middle East & Africa Blood Collection Devices Market Forecast to 2028 – COVID-19 Impact and Regional Analysis – by Product, Method, and End User,” the market was valued at US$ 296.00 million in 2022 and is expected to reach US$ 384.85 million by 2028; it is estimated to register a CAGR of 4.5% from 2022 to 2028. The report highlights the key factors driving the market and prominent players with their developments in the market.  

Blood collection tubes are sterile plastic or glass tubes that collect blood, urine, and serum samples from patients to diagnose blood-related diseases. Most blood collection devices comprise an additive that either accelerates the clotting of blood (clot activator) or prevents the blood from clotting (anticoagulant). The most commonly used blood collection devices comprise light-blue, red, green, lavender, gray, or gold mottled or "tiger" top. These tubes are generally used in clinical laboratories for coagulation, serology, immunology, and chemical  tests. The market growth is attributable to growing government support for blood test services and prevalence of blood and genetic disorders.

Middle East & Africa Blood Collection Devices Market, by Country (% Share)

To get free sample copy of the report, along with the TOC, Statistics, and Tables please visit @ https://www.theinsightpartners.com/sample/TIPRE00016324

Source: The Insight Partners Analysis

Market Opportunity

Innovative Blood Collection Devices Intended for Hemolysis

Innovative blood collection devices products may overcome the adverse effects of raw materials used in the manufacturing of blood collection devices. Innovative blood collection devices also offer a shorter coagulation time and effective separation of serum and blood clots. The utilization of smaller volume, blood collection devices intended for hemolysis procedures in emergency departments (EDs) may prove lucrative for the overall market growth in the upcoming years. Also, blood collection devices intended for hemolysis procedures will provide significant benefits for clinical research. Hemolytic specimens prove to be the most challenging preanalytical issues in laboratory diagnostics.

Therefore, product innovation with high-volume blood collection devices impacts positively as most severe hemolysis levels can be achieved through such high-volume blood collection devices (8ml/16x100mm). Additionally, reducing the hemolysis rate by using adequate collection systems could contribute to financial savings of up to US$ 6,340.22 per 10,000 samples during clinical research. Therefore, the type of blood collection devices influences in-vitro hemolysis for clinical tests. These aspects are likely to offer lucrative opportunities to the market players, which is expected to fuel the growth of the Middle East & Africa blood collection devices market in the coming years.

Impact of COVID-19 Pandemic on Middle East & Africa Blood Collection Devices Market:

In 2020, the COVID-19 pandemic significantly impacted the delivery and accessibility of social services, education, health and nutrition, healthcare spending, well-being, and development-related businesses. Owing to the dependence of Middle Eastern and African countries on trade and tourism, as well as struggles with substantial youth unemployment, the global crisis led to serious long-term effects. Governments in the Middle East & Africa allocated funds to prevent the overburdening of their health systems and decelerate the spread of COVID-19; a few countries also emphasized on increasing the number of intensive care units and hospital beds. The rising rate of SARS-CoV-2 has increased stress on the region's healthcare system, raising the demand for diagnostic tests such as blood tests or antibody tests in its healthcare system, supporting the growth of the market in this region. In June 2020, two of the largest private hospital groups in the UAE rolled out FDA-authorized COVID-19 serology tests available to the public. Thus, the aforementioned factors are likely to have positive impact on the market.

Becton, Dickinson, and Company; SARSEDT AG & CO.KG; Thermo Fisher Scientific, Inc.; Cardinal Health; Greiner Bio-One International GmbH; Terumo Corporation; ICU Medical, Inc.; Grifols, S.A.; Fresenius Kabi AG; and F.L. Medical S.R.L are among the leading companies operating in the Middle East & Africa blood collection devices market.

Based on product, the Middle East & Africa blood collection devices market is segmented into blood collection needles/holders, blood collection tubes, blood collection set, and others. The blood collection needles/holders segment held the largest market share in 2022. The blood collection tubes segment is likely to register the highest CAGR during the forecast period 2022–2028.

Based on method, the Middle East & Africa blood collection devices market is bifurcated into manual blood collection and automated blood collection. The manual blood collection segment held a larger market share in 2021. The automated blood collection segment is expected to register a higher CAGR during the forecast period.

In terms of end user, the Middle East & Africa blood collection devices market is categorized into hospitals & pathology laboratories, blood banks, and others. The hospitals & pathology laboratories segment held the largest share for Middle East & Africa blood collection tubes market share in 2022 and is expected to register the highest CAGR during the forecast period.

Contact Us
Contact Us: The Insight Partners 
Phone: +1-646-491-9876
Email Id: sales@theinsightpartners.com